NO975666L - Pyrrolderivater og medisinsk sammensetning - Google Patents
Pyrrolderivater og medisinsk sammensetningInfo
- Publication number
- NO975666L NO975666L NO975666A NO975666A NO975666L NO 975666 L NO975666 L NO 975666L NO 975666 A NO975666 A NO 975666A NO 975666 A NO975666 A NO 975666A NO 975666 L NO975666 L NO 975666L
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- aryl
- pharmaceutical composition
- medical composition
- alkyl
- Prior art date
Links
- 150000003233 pyrroles Chemical class 0.000 title abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 206010036018 Pollakiuria Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- -1 monoalkylamino Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/50—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14069895 | 1995-06-07 | ||
| PCT/JP1996/001526 WO1996040634A1 (en) | 1995-06-07 | 1996-06-06 | Pyrrole derivatives and medicinal composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO975666D0 NO975666D0 (no) | 1997-12-05 |
| NO975666L true NO975666L (no) | 1998-02-09 |
| NO321606B1 NO321606B1 (no) | 2006-06-12 |
Family
ID=15274666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19975666A NO321606B1 (no) | 1995-06-07 | 1997-12-05 | Pyrrolderivater og medisinsk sammensetning |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US5998459A (no) |
| EP (1) | EP0842923B1 (no) |
| JP (1) | JP3160910B2 (no) |
| KR (1) | KR100275222B1 (no) |
| CN (2) | CN1090617C (no) |
| AT (1) | ATE318799T1 (no) |
| AU (1) | AU710683B2 (no) |
| BR (1) | BR9608502A (no) |
| CA (1) | CA2223918C (no) |
| DE (1) | DE69635857T2 (no) |
| DK (1) | DK0842923T3 (no) |
| ES (1) | ES2259795T3 (no) |
| HU (1) | HUP9802290A3 (no) |
| MX (1) | MX9709475A (no) |
| NO (1) | NO321606B1 (no) |
| NZ (1) | NZ309151A (no) |
| PT (1) | PT842923E (no) |
| RU (1) | RU2166941C2 (no) |
| TW (1) | TW504503B (no) |
| WO (1) | WO1996040634A1 (no) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2223918C (en) * | 1995-06-07 | 2006-01-10 | Nippon Shinyaku Co., Ltd. | Pyrrole derivatives and medicinal composition |
| KR100485642B1 (ko) * | 1996-03-18 | 2005-09-30 | 에자이 가부시키가이샤 | 축합고리함유카르복실산유도체 |
| KR20010034114A (ko) * | 1998-01-14 | 2001-04-25 | 니뽄 신야쿠 가부시키가이샤 | 칼륨 채널 활성화제 |
| WO1999061016A1 (fr) * | 1998-05-27 | 1999-12-02 | Nippon Shinyaku Co., Ltd. | Inhibiteurs de cyclo-oxygenase-2 |
| KR20030019326A (ko) * | 2000-03-21 | 2003-03-06 | 니뽄 신야쿠 가부시키가이샤 | 방출 제어형 경구 투여 제제 |
| US20040067991A1 (en) * | 2000-07-06 | 2004-04-08 | Greig Nigel H | Tetrahydrobenzothiazole analogues as neuroprotective agents |
| TWI239952B (en) | 2001-03-14 | 2005-09-21 | Nippon Shinyaku Co Ltd | Stable crystals of pyrrole compound |
| US7759373B2 (en) * | 2001-04-16 | 2010-07-20 | Mitsubishi Tanabe Pharma Corporation | Large conductance calcium-activated K channel opener |
| TWI271402B (en) * | 2002-10-15 | 2007-01-21 | Tanabe Seiyaku Co | Large conductance calcium-activated K channel opener |
| EP1606284B1 (en) * | 2003-03-13 | 2009-12-02 | Vertex Pharmaceuticals Incorporated | Compositions useful as protein kinase inhibitors |
| US20050075359A1 (en) * | 2003-03-14 | 2005-04-07 | Rikako Kono | Large conductance calcium-activated K channel opener |
| GB0321509D0 (en) * | 2003-09-13 | 2003-10-15 | Astrazeneca Ab | Chemical compounds |
| WO2005037271A2 (en) * | 2003-10-17 | 2005-04-28 | Tanabe Seiyaku Co., Ltd. | Large conductance calcium-activated k channel opener |
| US7118801B2 (en) * | 2003-11-10 | 2006-10-10 | Gore Enterprise Holdings, Inc. | Aerogel/PTFE composite insulating material |
| ITTO20040125A1 (it) * | 2004-03-01 | 2004-06-01 | Rotta Research Lab | Nuove amidine eterocicliche inibitrici la produzione di ossido d'azoto (no) ad attivita' antinfiammatoria ed analgesica |
| JP2005325103A (ja) * | 2004-04-13 | 2005-11-24 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| JP5388574B2 (ja) * | 2005-05-31 | 2014-01-15 | バーテックス ファーマシューティカルズ インコーポレイテッド | イオンチャネルのモジュレーターとして有用なヘテロ環式類 |
| PE20070341A1 (es) * | 2005-07-29 | 2007-04-13 | Wyeth Corp | Derivados de pirrol como moduladores del receptor de progesterona |
| PE20070404A1 (es) * | 2005-07-29 | 2007-05-10 | Wyeth Corp | Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona |
| US8575338B2 (en) * | 2008-04-09 | 2013-11-05 | Mitsubishi Tanabe Pharma Corporation | Pyrimidine, pyridine and triazine derivatives as maxi-K channel openers |
| JP6596090B2 (ja) | 2014-12-17 | 2019-10-23 | キングス カレッジ ロンドン | レチノイン酸受容体ベータ（ＲＡＲβ）アゴニストとしてのビシクロヘテロアリール−ヘテロアリール−安息香酸化合物 |
| GB201610867D0 (en) | 2016-06-22 | 2016-08-03 | King S College London | Crystalline forms of a therapeutic compound and processes for their preparation |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD143426A1 (de) * | 1979-05-07 | 1980-08-20 | Karl Gewald | Verfahren zur herstellung von 5,6-kondensierten 4-amino-3-cyan-pyridonen-(2) |
| US4431823A (en) * | 1981-07-23 | 1984-02-14 | Hoffmann-La Roche Inc. | 1H-Pyrrole-3-carbonitrile-4(2-benzoyl)phenyl derivatives as intermediates for pyrrolo[3,4-D][2]benzazepines |
| FR2569189B1 (fr) * | 1984-08-14 | 1986-12-19 | Roussel Uclaf | Nouveaux derives du pyrrole, leur procede de preparation et leur application comme pesticides |
| SE8500273D0 (sv) * | 1985-01-22 | 1985-01-22 | Leo Ab | Nya tricykliska foreningar, kompositioner innehallande sadana foreningar, framstellningsforfaranden och behandlingsmetoder |
| JPH0637389B2 (ja) * | 1986-12-26 | 1994-05-18 | 北陸製薬株式会社 | 頻尿治療剤 |
| IL87222A (en) * | 1987-07-29 | 1993-04-04 | American Cyanamid Co | Arylpyrroles, methods for thepreparation thereof andinsecticidal, acaricidal andnematicidal compositionscontaining them |
| US4929634A (en) * | 1987-10-23 | 1990-05-29 | American Cyanamid Company | Method of and bait compositions for controlling mollusks |
| US4886625A (en) * | 1987-10-29 | 1989-12-12 | Miles Inc. | Functionalized conducting polymers and their use in diagnostic devices |
| DE3820190A1 (de) * | 1988-06-14 | 1989-12-21 | Cassella Ag | Pyrrolderivate, ihre herstellung und ihre verwendung als pharmazeutische wirkstoffe |
| EP0358047A3 (en) * | 1988-09-08 | 1991-05-29 | American Cyanamid Company | Method of controlling phytopathogenic fungi |
| US5021586A (en) * | 1989-03-31 | 1991-06-04 | Miles, Inc. | Dithiophenylpyrrole derivative monomers for preparing semi-conducting polymers |
| IT1233715B (it) * | 1989-07-14 | 1992-04-14 | Menarini Farma Ind | Uso in terapia della 10-ammino-5,6diidro-11h= dibenzo (b,e) azepina-6,11-dione e derivati, quali farmaci utili per il trattamento dell'incontinenza urinaria |
| US5210092A (en) * | 1990-09-25 | 1993-05-11 | Fujisawa Pharmaceutical Co., Ltd. | Angiotensin ii antagonizing heterocyclic derivatives |
| WO1993019067A1 (en) * | 1991-09-12 | 1993-09-30 | Fujisawa Pharmaceutical Co., Ltd. | Imidazopyridine derivatives as angiotensin ii antagonists |
| FR2698364B1 (fr) * | 1992-11-24 | 1995-01-27 | Synthelabo | Dérivés de pyrrole, leur préparation et leur application en thérapeutique. |
| FR2706899A1 (en) * | 1993-06-22 | 1994-12-30 | Synthelabo | Pyrrole derivatives, their preparation and their therapeutic application |
| US5359090A (en) * | 1993-12-29 | 1994-10-25 | American Cyanamid Company | Alkoxymethylation of pyrroles |
| CA2223918C (en) * | 1995-06-07 | 2006-01-10 | Nippon Shinyaku Co., Ltd. | Pyrrole derivatives and medicinal composition |
-
1996
- 1996-06-06 CA CA002223918A patent/CA2223918C/en not_active Expired - Fee Related
- 1996-06-06 DE DE69635857T patent/DE69635857T2/de not_active Expired - Lifetime
- 1996-06-06 BR BR9608502A patent/BR9608502A/pt not_active Application Discontinuation
- 1996-06-06 DK DK96916319T patent/DK0842923T3/da active
- 1996-06-06 WO PCT/JP1996/001526 patent/WO1996040634A1/ja not_active Ceased
- 1996-06-06 CN CN96194448A patent/CN1090617C/zh not_active Expired - Fee Related
- 1996-06-06 KR KR1019970708809A patent/KR100275222B1/ko not_active Expired - Fee Related
- 1996-06-06 PT PT96916319T patent/PT842923E/pt unknown
- 1996-06-06 NZ NZ309151A patent/NZ309151A/xx not_active IP Right Cessation
- 1996-06-06 JP JP50031097A patent/JP3160910B2/ja not_active Expired - Fee Related
- 1996-06-06 AU AU59109/96A patent/AU710683B2/en not_active Ceased
- 1996-06-06 US US08/973,369 patent/US5998459A/en not_active Expired - Fee Related
- 1996-06-06 MX MX9709475A patent/MX9709475A/es not_active IP Right Cessation
- 1996-06-06 AT AT96916319T patent/ATE318799T1/de not_active IP Right Cessation
- 1996-06-06 HU HU9802290A patent/HUP9802290A3/hu unknown
- 1996-06-06 ES ES96916319T patent/ES2259795T3/es not_active Expired - Lifetime
- 1996-06-06 EP EP96916319A patent/EP0842923B1/en not_active Expired - Lifetime
- 1996-06-06 RU RU98100090/14A patent/RU2166941C2/ru not_active IP Right Cessation
- 1996-06-18 TW TW085107349A patent/TW504503B/zh not_active IP Right Cessation
-
1997
- 1997-12-05 NO NO19975666A patent/NO321606B1/no unknown
-
1999
- 1999-07-30 US US09/365,096 patent/US6172102B1/en not_active Expired - Fee Related
-
2001
- 2001-10-15 CN CN01135586A patent/CN1349796A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0842923A1 (en) | 1998-05-20 |
| EP0842923A4 (en) | 1999-12-29 |
| AU5910996A (en) | 1996-12-30 |
| CA2223918A1 (en) | 1996-12-19 |
| HUP9802290A2 (hu) | 1999-10-28 |
| RU2166941C2 (ru) | 2001-05-20 |
| ATE318799T1 (de) | 2006-03-15 |
| NZ309151A (en) | 2000-01-28 |
| WO1996040634A1 (en) | 1996-12-19 |
| KR100275222B1 (ko) | 2001-02-01 |
| KR19990022329A (ko) | 1999-03-25 |
| DE69635857T2 (de) | 2006-10-19 |
| BR9608502A (pt) | 1999-07-06 |
| JP3160910B2 (ja) | 2001-04-25 |
| CN1090617C (zh) | 2002-09-11 |
| HUP9802290A3 (en) | 2002-02-28 |
| TW504503B (en) | 2002-10-01 |
| US5998459A (en) | 1999-12-07 |
| ES2259795T3 (es) | 2006-10-16 |
| CN1349796A (zh) | 2002-05-22 |
| NO975666D0 (no) | 1997-12-05 |
| DK0842923T3 (da) | 2006-06-19 |
| EP0842923B1 (en) | 2006-03-01 |
| CN1186485A (zh) | 1998-07-01 |
| MX9709475A (es) | 1998-02-28 |
| US6172102B1 (en) | 2001-01-09 |
| NO321606B1 (no) | 2006-06-12 |
| CA2223918C (en) | 2006-01-10 |
| DE69635857D1 (de) | 2006-04-27 |
| PT842923E (pt) | 2006-07-31 |
| AU710683B2 (en) | 1999-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO975666L (no) | Pyrrolderivater og medisinsk sammensetning | |
| FI950309A0 (fi) | Proliiniamidijohdannaisia | |
| DE69604714D1 (de) | Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen | |
| EA200100983A1 (ru) | Производные 13-метилэритромицина | |
| DK0651999T3 (da) | Fremgangsmåder til inhibering af livmoderfibrose | |
| DK0652000T3 (da) | Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et lægemiddel til inhibering af angiogenese og angiogene sygdomme | |
| DK0659416T3 (da) | Inhibering af seborE og acne | |
| DK0652002T3 (da) | Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning | |
| DE69215694D1 (de) | Benzamid-derivate | |
| DK0682947T3 (da) | Medikament til terapeutisk og profylaktisk behandling af sygdomme forårsaget af glatmuskelcelle-hyperplasi | |
| DE60009517D1 (de) | A-500359-derivate | |
| NO894325D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater. | |
| DE69327077D1 (de) | Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen | |
| ATE241985T1 (de) | Therapeutisches mittel zur behandlung von nierenerkrankungen | |
| DE69220371D1 (de) | Hemmstoff der blutgefässhypertrophie |